Josh Makower, CEO of ExploraMed, defines a business model and talks about its critical role in ensuring the sustainability of an organization.

Josh Makower, CEO of ExploraMed, explains the types of business models and how to determine which one provides the right fit.

Josh Makower, CEO of ExploraMed, talks about when adaptations of traditional business models can be a source of innovation.

Josh Makower, co-founder and CEO of ExploraMed, comments on clinical requirements in the current medtech environment and the strategic implications to innovators.

Josh Makower, co-founder and CEO of ExploraMed, discussed clinical trial design and why randomized, controlled trials may not always be the optimal approach.

Josh Makower, co-founder and CEO of ExploraMed, touches on some of the important factors to consider when choosing a location for clinical trials.

Josh Makower, co-founder and CEO of ExploraMed, highlights some of the strategic challenges associated with self-pay technologies targeted at healthcare consumers, as well as where near-term self-pay opportunities exist.

Josh Makower, co-founder and CEO of ExploraMed, outlines important advantages and disadvantages for innovators to evaluate when considering a self-pay solution.

Josh Makower, co-founder and CEO of ExploraMed, comments on key differences when designing self-pay products for physicians versus patients.

Josh Makower, co-founder and CEO of ExploraMed, touches on self-pay opportunities outside the U.S.

Faculty, fellows, and advisors to the Stanford Biodesign program discuss challenges and opportunities associated with the strategy development stage of the biodesign innovation process.

Faculty, fellows, and advisors to the Stanford Biodesign program describe the business planning stage of the biodesign innovation process and offer guidance for pursuing opportunities in the medtech sector.